Short-Term Outcomes of Single-Arm Sacrocolpopexy with Autologous Fascia Lata.

Sascha Vereeck, Victoria Buckley, Anna Rosamilia

Abstract read

In one paragraph

Article in International urogynecology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sascha VereeckDepartment of Obstetrics and Gynaecology, Antwerp University Hospital, University of Antwerp, Antwerp, Belgium. Sascha.vereeck@uza.be.ORCID 0000-0002-9990-2252

Victoria BuckleyRoyal Prince Alfred Hospital, Camperdown, NSW, Australia.

Anna RosamiliaPelvic Floor Unit, Monash Health, Monash University, Clayton, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introduction and hypothesisSacrocolpopexy (ASC) is the gold standard for apical and multicompartment prolapse. With no approved mesh available in Australia, fascia lata (FL) is being offered as an alternative graft. The aim was to examine the outcomes of FL ASC.

methodsProspective cohort study of women with ≥ stage 2 prolapse undergoing FL ASC with at least 6 months follow-up. Primary outcome was defined as Patient Global Impression of Improvement (PGI-I). Secondary outcomes were Australian Pelvic Floor Questionnaire (APFQ), Pelvic Organ Prolapse Quantification (POP-Q) System and safety (Clavien Dindo Classification (CDC)). SPSS v29 was used for statistical analysis. Descriptive statistics, chi-square and paired t-test were used.

resultsFrom Feb 2022 to Jun 2025, 131 were planned for the procedure, seven were excluded from the overal analysis, leaving 124. Of those remaining, 101 (81.5%) had at least 6 months follow-up with a median follow-up of 12 months (range 6-39 months). Mean age and BMI were 67 years and 27 kg/m

conclusionsOur study suggests that FL may be a promising graft for ASC, with high patient satisfaction scores and low major complication rate.

Indexed as

Fascia LataGynecologic Surgical ProceduresPelvic Organ ProlapseAgedFemaleFollow-Up StudiesHumansMiddle AgedProspective StudiesTransplantation, AutologousTreatment OutcomeAutologous fascia lataPelvic organ prolapsePelvic reconstructive surgerySacrocolpopexySacrohysteropexy

Identifiers

PMID41191074

DOI10.1007/s00192-025-06424-3

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.